Spots Global Cancer Trial Database for Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
Official Title: Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
Study ID: NCT05651828
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to compare how well tolerated and effective four different dosing schedules (two personalized, intermittent dosing schedules as compared to a fixed intermittent and continuous dosing regimen) work in people with advanced basal cell carcinoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Moffitt Cancer Center, Tampa, Florida, United States
Contact Details
Name: Zeynep Eroglu, MD
Affiliation: Moffitt Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
